{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:01:04Z","timestamp":1648609264951},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T00:00:00Z","timestamp":1449792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00345-015-1737-7","type":"journal-article","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T08:32:48Z","timestamp":1449822768000},"page":"1155-1161","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent"],"prefix":"10.1007","volume":"34","author":[{"given":"Aur\u00e9lie","family":"Mbeutcha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Lucca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"de Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Haitel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evanguelos","family":"Xylinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malte","family":"Rieken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon Z.","family":"Weizer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Rioux-Leclecq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bolenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Bensalah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Remzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,11]]},"reference":[{"key":"1737_CR1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","volume":"63","author":"M Roupr\u00eat","year":"2013","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat E et al (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63:1059","journal-title":"Eur Urol"},{"key":"1737_CR2","doi-asserted-by":"publisher","unstructured":"Ploussard G, Xylinas E, Lotan Y et al (2014) Conditional survival after radical nephroureterectomy for upper tract carcinoma. Eur Urol 67(4):803\u2013812. doi: 10.1016\/j.eururo.2014.08.003","DOI":"10.1016\/j.eururo.2014.08.003"},{"key":"1737_CR3","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.juro.2012.10.057","volume":"189","author":"M Roupr\u00eat","year":"2013","unstructured":"Roupr\u00eat M, Hupertan V, Seisen T et al (2013) Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol 189:1662","journal-title":"J Urol"},{"issue":"1","key":"1737_CR4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/bju.12801","volume":"116","author":"I Lucca","year":"2015","unstructured":"Lucca I, Kassouf W, Kapoor A et al (2015) The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study. BJU Int 116(1):72\u201378","journal-title":"BJU Int"},{"key":"1737_CR5","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.juro.2009.05.011","volume":"182","author":"NJ Hellenthal","year":"2009","unstructured":"Hellenthal NJ, Shariat SF, Margulis V et al (2009) Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol 182:900","journal-title":"J Urol"},{"key":"1737_CR6","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.28655","volume":"120","author":"S Porten","year":"2014","unstructured":"Porten S, Siefker-Radtke AO, Xiao L et al (2014) Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer 120:1794","journal-title":"Cancer"},{"key":"1737_CR7","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/bjc.2013.462","volume":"109","author":"JH Ku","year":"2013","unstructured":"Ku JH, Moon KC, Jung JH et al (2013) External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma. Br J Cancer 109:1130","journal-title":"Br J Cancer"},{"key":"1737_CR8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","volume":"61","author":"EK Cha","year":"2012","unstructured":"Cha EK, Shariat SF, Kormaksson M et al (2012) Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 61:818","journal-title":"Eur Urol"},{"issue":"5","key":"1737_CR9","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.juro.2014.11.007","volume":"193","author":"L-M Krabbe","year":"2015","unstructured":"Krabbe L-M, Bagrodia A, Haddad AQ et al (2015) Multi-institutional validation of the predictive value of KI-67 in patients with high-grade urothelial carcinoma of the upper urinary tract. J Urol 193(5):1486\u20131493","journal-title":"J Urol"},{"key":"1737_CR10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.eururo.2013.12.008","volume":"66","author":"DJ Lee","year":"2014","unstructured":"Lee DJ, Xylinas E, Rieken M et al (2014) Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma. Eur Urol 66:379","journal-title":"Eur Urol"},{"key":"1737_CR11","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.eururo.2007.09.036","volume":"52","author":"K Bensalah","year":"2007","unstructured":"Bensalah K, Montorsi F, Shariat SF (2007) Challenges of cancer biomarker profiling. Eur Urol 52:1601","journal-title":"Eur Urol"},{"key":"1737_CR12","doi-asserted-by":"crossref","unstructured":"Friedberg EC (2001) How nucleotide excision repair protects against cancer. Nat Rev Cancer 1(1):22\u201333","DOI":"10.1038\/35094000"},{"key":"1737_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mc.20069","volume":"42","author":"AS Neumann","year":"2005","unstructured":"Neumann AS, Sturgis EM, Wei Q (2005) Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog 42:65","journal-title":"Mol Carcinog"},{"key":"1737_CR14","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I et al (2012) Molecular mechanisms of cisplatin resistance. Oncogene 31:1869","journal-title":"Oncogene"},{"key":"1737_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0027-5107(01)00141-5","volume":"478","author":"M Kartalou","year":"2001","unstructured":"Kartalou M, Essigmann JM (2001) Mechanisms of resistance to cisplatin. Mutat Res 478:23","journal-title":"Mutat Res"},{"key":"1737_CR16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","volume":"355","author":"KA Olaussen","year":"2006","unstructured":"Olaussen KA, Dunant A, Fouret P et al (2006) DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355:983","journal-title":"N Engl J Med"},{"key":"1737_CR17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/annonc\/mdl435","volume":"18","author":"J Bellmunt","year":"2007","unstructured":"Bellmunt J, Paz-Ares L, Cuello M et al (2007) Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy. Ann Oncol 18:522","journal-title":"Ann Oncol"},{"key":"1737_CR18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.lungcan.2013.08.018","volume":"82","author":"F Mazzoni","year":"2013","unstructured":"Mazzoni F, Cecere FL, Meoni G et al (2013) Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer. Lung Cancer 82:288","journal-title":"Lung Cancer"},{"key":"1737_CR19","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/cncr.28714","volume":"120","author":"G Bepler","year":"2014","unstructured":"Bepler G, Zinner RG, Moon J et al (2014) A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701). Cancer 120:2343","journal-title":"Cancer"},{"key":"1737_CR20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.urolonc.2013.11.010","volume":"32","author":"T Klatte","year":"2014","unstructured":"Klatte T, Xylinas E, Rieken M et al (2014) Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy. Urol Oncol 32:625","journal-title":"Urol Oncol"},{"key":"1737_CR21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.eururo.2011.12.055","volume":"61","author":"M Rink","year":"2012","unstructured":"Rink M, Fajkovic H, Cha EK et al (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61:854","journal-title":"Eur Urol"},{"key":"1737_CR22","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/bjc.2013.83","volume":"108","author":"P Li","year":"2013","unstructured":"Li P, Fang YJ, Li F et al (2013) ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy. Br J Cancer 108:1238","journal-title":"Br J Cancer"},{"key":"1737_CR23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.127.3.978","volume":"127","author":"GR Simon","year":"2005","unstructured":"Simon GR, Sharma S, Cantor A et al (2005) ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer. Chest 127:978","journal-title":"Chest"},{"key":"1737_CR24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1593\/neo.10402","volume":"12","author":"A Hoffmann","year":"2010","unstructured":"Hoffmann A, Wild P, Leicht C et al (2010) MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Neoplasia 12:628","journal-title":"Neoplasia"},{"key":"1737_CR25","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1158\/1078-0432.CCR-10-1963","volume":"17","author":"A Kawashima","year":"2011","unstructured":"Kawashima A, Nakayama M, Kakuta Y et al (2011) Excision repair cross-complementing group 1 may predict the efficacy of chemoradiation therapy for muscle-invasive bladder cancer. Clin Cancer Res 17:2561","journal-title":"Clin Cancer Res"},{"key":"1737_CR26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/CAD.0000000000000021","volume":"25","author":"S Li","year":"2014","unstructured":"Li S, Wu J, Chen Y et al (2014) ERCC1 expression levels predict the outcome of platinum-based chemotherapies in advanced bladder cancer: a meta-analysis. Anticancer Drugs 25:106","journal-title":"Anticancer Drugs"},{"key":"1737_CR27","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.juro.2015.06.099","volume":"194","author":"T Klatte","year":"2015","unstructured":"Klatte T, Seitz C, Rink M et al (2015) ERCC1 as a prognostic and predictive biomarker for urothelial carcinoma of the bladder following radical cystectomy. J Urol 194(5):1456\u20131462. doi: 10.1016\/j.juro.2015.06.099","journal-title":"J Urol"},{"key":"1737_CR28","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2013.52.4785","volume":"32","author":"TK Choueiri","year":"2014","unstructured":"Choueiri TK, Jacobus S, Bellmunt J et al (2014) Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates. J Clin Oncol 32:1889","journal-title":"J Clin Oncol"},{"key":"1737_CR29","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","volume":"189","author":"DA Green","year":"2013","unstructured":"Green DA, Rink M, Xylinas E et al (2013) Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol 189:1214","journal-title":"J Urol"},{"key":"1737_CR30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2009.08.115","volume":"183","author":"SF Shariat","year":"2010","unstructured":"Shariat SF, Chade DC, Karakiewicz PI et al (2010) Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. J Urol 183:68","journal-title":"J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-015-1737-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-015-1737-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-015-1737-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:40:25Z","timestamp":1559050825000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-015-1737-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,11]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1737"],"URL":"https:\/\/doi.org\/10.1007\/s00345-015-1737-7","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,11]]}}}